Effect of moxifloxacin versus imipenem/cilastatin treatment on the mortality of mice infected intravenously with different strains of Bacteroides fragilis and Escherichia coli | Zendy

Reiner Schaumann | Zendy

Open Access

Effect of moxifloxacin versus imipenem/cilastatin treatment on the mortality of mice infected intravenously with different strains of Bacteroides fragilis and Escherichia coli

Author(s) -

Reiner Schaumann

Publication year - 2004

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkh089

Subject(s) - bacteroides fragilis , moxifloxacin , imipenem , microbiology and biotechnology , imipenem/cilastatin , cilastatin , antibiotics , antibacterial agent , bacteroides , escherichia coli , medicine , biology , bacteria , antibiotic resistance , biochemistry , genetics , gene

To study the effect of moxifloxacin versus imipenem/cilastatin (hereafter referred to as imipenem) treatment on the mortality of mice infected intravenously with different strains of Bacteroides fragilis and Escherichia coli.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research